Bioceltix S.A. (WSE:BCX)
89.50
+1.60 (1.82%)
Jun 12, 2026, 5:00 PM CET
Bioceltix Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 60.79 | 68.4 | 33.63 | 9.31 | 4.12 | 6.05 |
Cash & Short-Term Investments | 60.79 | 68.4 | 33.63 | 9.31 | 4.12 | 6.05 |
Cash Growth | 86.64% | 103.38% | 261.24% | 125.98% | -31.96% | - |
Accounts Receivable | - | - | 0 | 0 | 0 | - |
Other Receivables | 4.09 | 2.85 | 4.98 | 1.88 | 0.23 | 0.44 |
Receivables | 4.09 | 2.85 | 4.98 | 1.88 | 0.23 | 0.44 |
Inventory | 0.2 | - | 0.01 | 0.01 | - | - |
Prepaid Expenses | - | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 |
Other Current Assets | - | 0.02 | 0.01 | 0 | 1.67 | 0.01 |
Total Current Assets | 65.08 | 71.29 | 38.66 | 11.21 | 6.02 | 6.51 |
Property, Plant & Equipment | 5.11 | 3.88 | 2.37 | 1.48 | 1.46 | 1.53 |
Long-Term Deferred Tax Assets | 0.05 | 0.05 | 0.03 | 0.04 | 0.03 | 0.02 |
Other Long-Term Assets | 0.37 | 0.41 | 0.03 | - | 0.14 | 0.14 |
Total Assets | 70.61 | 75.63 | 41.09 | 12.74 | 7.65 | 8.2 |
Accounts Payable | - | 0.64 | 0.37 | 1.21 | 0.96 | 0.29 |
Accrued Expenses | 0.46 | 0.77 | 0.56 | 0.44 | 0.34 | 0.19 |
Current Portion of Leases | - | 0.23 | 0.67 | 0.1 | 0.12 | 0.38 |
Current Income Taxes Payable | - | 0.56 | 0.46 | 0.36 | 0.27 | 0.12 |
Current Unearned Revenue | - | - | 0.01 | 0.03 | 0.56 | 0.93 |
Total Current Liabilities | 2.89 | 2.19 | 2.07 | 2.14 | 2.25 | 1.91 |
Long-Term Leases | - | 0.09 | 0.15 | 0.08 | 0.18 | 0.15 |
Long-Term Unearned Revenue | - | - | - | - | 0.03 | 0.06 |
Pension & Post-Retirement Benefits | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
Long-Term Deferred Tax Liabilities | 0.07 | 0.07 | 0.07 | 0.04 | 0.04 | 0.07 |
Total Liabilities | 3.02 | 2.36 | 2.31 | 2.27 | 2.5 | 2.2 |
Common Stock | 0.55 | 0.55 | 0.49 | 0.41 | 0.34 | 0.33 |
Additional Paid-In Capital | 87.51 | 87.52 | 52.82 | 23.8 | 14.44 | 15.14 |
Retained Earnings | -20.48 | -14.8 | -14.54 | -13.74 | -13.99 | -9.47 |
Comprehensive Income & Other | - | - | - | - | 4.36 | - |
Shareholders' Equity | 67.59 | 73.28 | 38.78 | 10.47 | 5.15 | 6 |
Total Liabilities & Equity | 70.61 | 75.63 | 41.09 | 12.74 | 7.65 | 8.2 |
Total Debt | - | 0.31 | 0.82 | 0.18 | 0.29 | 0.53 |
Net Cash (Debt) | 60.79 | 68.09 | 32.81 | 9.14 | 3.83 | 5.52 |
Net Cash Growth | 90.52% | 107.53% | 259.15% | 138.76% | -30.74% | - |
Net Cash Per Share | 11.80 | 13.62 | 7.23 | 2.33 | 1.15 | 1.75 |
Filing Date Shares Outstanding | 5.53 | 5.53 | 4.92 | 4.13 | 3.98 | 3.29 |
Total Common Shares Outstanding | 5.53 | 5.53 | 4.92 | 4.13 | 3.43 | 3.29 |
Working Capital | 62.2 | 69.1 | 36.59 | 9.07 | 3.78 | 4.61 |
Book Value Per Share | 12.22 | 13.25 | 7.87 | 2.53 | 1.50 | 1.82 |
Tangible Book Value | 67.59 | 73.28 | 38.78 | 10.47 | 5.15 | 6 |
Tangible Book Value Per Share | 12.22 | 13.25 | 7.87 | 2.53 | 1.50 | 1.82 |
Buildings | - | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 |
Machinery | - | 0.41 | 0.3 | 0.27 | 0.24 | 0.25 |
Construction In Progress | - | 1.78 | 0.1 | - | - | - |